Serendipitous identification of natural Intergenotypic recombinants of hepatitis C in Ireland

被引:53
作者
Moreau, Isabelle
Hegarty, Susan
Levis, John
Sheehy, Patrick
Crosbie, Orla
Kenny-Walsh, Elizabeth
Fanning, Liam J. [1 ]
机构
[1] Cork Univ Hosp, Dept Med, Mol Virol Diagnost & Res Lab, Cork, Ireland
[2] Cork Univ Hosp, Dept Gastroenterol, Cork, Ireland
关键词
D O I
10.1186/1743-422X-3-95
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Background: Recombination between hepatitis C single stranded RNA viruses is a rare event. Natural viable intragenotypic and intergenotypic recombinants between 1b-1a, 1a-1c and 2k-1b, 2i-6p, respectively, have been reported. Diagnostically recombinants represent an intriguing challenge. Hepatitis C genotype is defined by interrogation of the sequence composition of the 5' untranslated region [5' UTR]. Occasionally, ambiguous specimens require further investigation of the genome, usually by interrogation of the NS5B region. The original purpose of this study was to confirm the existence of a suspected mixed genotype infection of genotypes 2 and 4 by clonal analysis at the NS5B region of the genome in two specimens from two separate individuals. This initial identification of genotype was based on analysis of the 5' UTR of the genome by reverse line probe hybridisation [RLPH]. Results: The original diagnosis of a mixed genotype infection was not confirmed by clonal analysis of the NS5B region of the genome. The phylogenetic analysis indicated that both specimens were natural intergenotypic recombinant forms of HCV. The recombination was between genotypes 2k and 1b for both specimens. The recombination break point was identified as occurring within the NS2 region of the genome. Conclusion: The viral recombinants identified here resemble the recombinant form originally identified in Russia. The RLPH pattern observed in this study may be a signature indicative of this particular type of intergenotype recombinant of hepatitis C meriting clonal analysis of NS2.
引用
收藏
页数:7
相关论文
共 21 条
[1]  
[Anonymous], 1995, Phylogeny inference package (PHYLIP)
[2]   Evidence of structural genomic region recombination in Hepatitis C virus [J].
Cristina, Juan ;
Colina, Rodney .
VIROLOGY JOURNAL, 2006, 3 (1)
[3]   Viral load and clinicopathological features of chronic hepatitis C (1b) in a homogeneous patient population [J].
Fanning, L ;
Kenny, E ;
Sheehan, M ;
Cannon, B ;
Whelton, M ;
O'Connell, J ;
Collins, JK ;
Shanahan, F .
HEPATOLOGY, 1999, 29 (03) :904-907
[4]   LACK OF PROTECTIVE IMMUNITY AGAINST REINFECTION WITH HEPATITIS-C VIRUS [J].
FARCI, P ;
ALTER, HJ ;
GOVINDARAJAN, S ;
WONG, DC ;
ENGLE, R ;
LESNIEWSKI, RR ;
MUSHAHWAR, IK ;
DESAI, SM ;
MILLER, RH ;
OGATA, N ;
PURCELL, RH .
SCIENCE, 1992, 258 (5079) :135-140
[5]   Susceptibility to antiretroviral drugs of CRF01_AE, CRF02_AG, and subtype C viruses from untreated patients of Africa and Asia: Comparative genotypic and phenotypic data [J].
Fleury, HJ ;
Toni, T ;
Lan, NTH ;
Hung, PV ;
Deshpande, A ;
Recordon-Pinson, P ;
Boucher, S ;
Lazaro, E ;
Jauvin, V ;
Lavignolle-Aurillac, V ;
Lebel-Binay, S ;
Cheret, A ;
Masquelier, B .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2006, 22 (04) :357-366
[6]   Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. [J].
Fried, MW ;
Shiffman, ML ;
Reddy, KR ;
Smith, C ;
Marinos, G ;
Goncales, FL ;
Haussinger, D ;
Diago, M ;
Carosi, G ;
Dhumeaux, D ;
Craxi, A ;
Lin, A ;
Hoffman, J ;
Yu, J .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (13) :975-982
[7]   Hepatitis C virus genotyping based on 5′ noncoding sequence analysis (Trugene) [J].
Halfon, P ;
Trimoulet, P ;
Bourliere, M ;
Khiri, H ;
de Lédinghen, V ;
Couzigou, P ;
Feryn, JM ;
Alcaraz, P ;
Renou, C ;
Fleury, HJA ;
Ouzan, D .
JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (05) :1771-1773
[8]   A galloping horse model [J].
Herr, HM ;
McMahon, TA .
INTERNATIONAL JOURNAL OF ROBOTICS RESEARCH, 2001, 20 (01) :26-37
[9]   Global burden of disease (GBD) for hepatitis C [J].
Hutin, Y ;
Kitler, ME ;
Dore, GJ ;
Perz, JF ;
Armstrong, GL ;
Dusheiko, G ;
Ishibashi, H ;
Grob, P ;
Kew, M ;
Marcellin, P ;
Seeff, LB ;
Beutels, P ;
Nelson, C ;
Stein, C ;
Zurn, P ;
Clifford, G ;
Vranckx, R ;
Alberti, A ;
Hallaj, ZS ;
Hadler, S ;
Lavanchy, D .
JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 44 (01) :20-29
[10]   Full-length open reading frame of a recombinant hepatitis C virus strain from St Petersburg: proposed mechanism for its formation [J].
Kalinina, O ;
Norder, H ;
Magnius, LO .
JOURNAL OF GENERAL VIROLOGY, 2004, 85 :1853-1857